Gene

FGF13

fibroblast growth factor 13

Explore in graph →CI-GENE-00001904HGNC:3670 ENSG00000129682 NCBI 2258 CIViC Cancer geneApproved

Curated evidence

Clinical evidence (1)

CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.

civicCuratedShowing 1–1 of 1 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.

Therapy	Cancer	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
FGF13 CYTOPLASMIC EXPRESSION1
(prognostic)	Malignant Prostate Neoplasm	Prognostic	B	Supports Poor Outcome	3	accepted	EID1062 243 primary PCa, 37 metastatic PCa, and 20 castration-resistant PCa (CRPC) specimens underwent IHC and microarray analysis. Immunohistochemistry (IHC) showed that FGF13 was detectable in the major… (full text at CIViC) PMID 26891277 · Yu et al., 2016 · Open in CIViC	civic

Cohorts

Alteration frequency by cohort (1)

Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.

cbioportalObserved1 cohort row · frequency = affected / profiled, as published by each cohort; cohorts are not pooled. Hover a row badge for its release.

Cohort	Mapped cancer	Alteration	Affected (n)	Profiled (n)	Frequency (%)	Rank in cohort	Source
Rhabdomyosarcoma (NIH, Cancer Discov 2014) rms_nih_2014	Rhabdomyosarcoma	Ssm	1	43	2.3%

Literature

Linked publications (1)

25 per page, newest first.

pubmedPublishedShowing 1–1 of 1 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy.
· Int J Cancer · 2016 · PMID 26891277 · validated civic_curation pubmed